GCP

HOUSTON, TEXAS, May 04, 2026 Cellenkos has announced that the U.S. Food and Drug Administration (FDA) has granted Investigational...

SAN DIEGO, CALIFORNIA, May 03, 2026 UCB has announced a definitive agreement to acquire Candid Therapeutics in a transaction...

BOSTON, MASSACHUSETTS, May 04, 2026 Ascidian Therapeutics has announced the completion of the adult dose escalation phase in its...

BRIDGEWATER, NEW JERSEY, May 04, 2026 Insmed Incorporated has announced the presentation of multiple clinical and real-world data sets...

SEATTLE, WASHINGTON, May 04, 2026 Atossa Therapeutics has announced that the U.S. Food and Drug Administration (FDA) has granted...

MINNEAPOLIS, MINNESOTA, May 01, 2026 Celcuity has announced positive topline results from its Phase 3 VIKTORIA-1 trial, demonstrating a...

RESEARCH TRIANGLE PARK, NORTH CAROLINA, May 04, 2026 BioCryst Pharmaceuticals has announced a strategic European licensing agreement with an...

BOSTON, MASSACHUSETTS, April 30, 2026 Bambusa Therapeutics has announced the successful completion of patient enrollment in its Phase 1b/2a...

BEIJING, CHINA, April 27, 2026 Huahui Health has announced a global exclusive option, license, and collaboration agreement with BeOne...

FREDERICK, MARYLAND, April 30, 2026 Theradaptive has received U.S. Food and Drug Administration (FDA) authorization to advance its OASIS...